Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,084 across all filing types
Latest filing 2026-04-07 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
重大信息内部保密制度
Governance Information Classification · 95% confidence The document is titled '重大信息内部保密制度' which translates to 'Major Information Internal Confidentiality System' and is issued by 西藏易明西雅医药科技股份有限公司. It outlines the company's internal policies and procedures for handling and protecting material non-public information, insider information, confidentiality obligations, and penalties for violations. The content focuses on internal governance, compliance with securities laws, and insider trading prevention. There are no financial statements, earnings data, or investor presentations. It is a governance-related document detailing internal rules and procedures for information confidentiality and insider information management. Therefore, it fits best under Governance Information (CGR). The document length (5518 characters) and detailed policy content support this classification rather than a brief announcement or regulatory filing.
2026-04-07 Chinese
重大信息内部报告制度
Governance Information Classification · 95% confidence The document is titled '重大信息内部报告制度' which translates to 'Major Information Internal Reporting System'. It is a detailed internal policy document outlining the procedures and responsibilities for reporting major information within the company. It references various laws and regulations related to corporate governance and information disclosure, but it is not a financial report, earnings release, or any form of external regulatory filing. It does not contain financial statements, audit opinions, or shareholder meeting materials. Instead, it is a governance-related internal control document focused on information reporting and compliance. Therefore, it fits best under Governance Information (CGR). The document length (6322 characters) and content confirm it is a substantive policy document rather than a brief announcement or certification.
2026-04-07 Chinese
会计师事务所选聘制度
Governance Information Classification · 95% confidence The document is titled '会计师事务所选聘制度' which translates to 'Accounting Firm Selection System' and details the procedures, requirements, and governance related to the selection and appointment of the company's external auditors. It includes references to laws, company bylaws, and internal governance processes for appointing accounting firms. There are no financial statements, audit opinions, or actual audit reports included. Instead, it is a policy or governance document outlining how the company selects and manages its auditors. This fits best under Governance Information (CGR), as it details internal rules and governance practices related to auditor selection rather than being an audit report or annual report itself.
2026-04-07 Chinese
董事会提名委员会工作细则
Governance Information Classification · 100% confidence The document is titled '董事会提名委员会工作细则' which translates to 'Board Nomination Committee Working Rules'. It details the structure, responsibilities, composition, and procedures of the company's board nomination committee. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no legal proceedings, no capital changes, and no meeting materials. The content is focused on governance practices related to board nominations and management appointments. This fits the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2026-04-07 Chinese
关于向2026年限制性股票激励计划激励对象首次授予限制性股票的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the initial grant of restricted stock under a 2026 restricted stock incentive plan by the company 西藏易明西雅医药科技股份有限公司. It details the number of shares granted, the grant price, the recipients, vesting and performance conditions, and legal and board approvals. The document is a formal announcement of a share-based incentive plan grant, including details on stock source, approval procedures, and legal opinions. It does not contain financial statements or quarterly/yearly financial results, nor is it a transcript, audit report, or regulatory certification. It is not a report publication announcement but a detailed announcement of a capital/financing-related event (stock incentive plan grant). Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2026-03-11 Chinese
第四届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the fourth meeting of the fourth board of directors of the company. It details the meeting attendance, the approval of a restricted stock incentive plan, voting results, and references to related legal opinions and documents. There is no financial data or comprehensive report content. The document is a formal announcement of board decisions, specifically about management and board matters, not a full management report or financial report. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2026-03-11 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.